INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
8.01
-0.05 (-0.62%)
May 14, 2025, 9:44 AM - Market open
INmune Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 19.34 | 20.92 | 35.85 | 52.15 | 74.81 | 21.97 | Upgrade
|
| Cash & Short-Term Investments | 19.34 | 20.92 | 35.85 | 52.15 | 74.81 | 21.97 | Upgrade
|
| Cash Growth | -25.63% | -41.64% | -31.26% | -30.29% | 240.56% | 214.02% | Upgrade
|
| Other Receivables | 1.42 | 1.41 | 2.44 | 8.46 | 5.5 | 1.8 | Upgrade
|
| Receivables | 1.42 | 1.41 | 2.44 | 8.46 | 5.5 | 1.8 | Upgrade
|
| Prepaid Expenses | 0.21 | 0.33 | 1.65 | 4.06 | 2.29 | 0.22 | Upgrade
|
| Total Current Assets | 20.96 | 22.66 | 39.94 | 64.68 | 82.61 | 23.99 | Upgrade
|
| Property, Plant & Equipment | 0.28 | 0.31 | 0.41 | 0.51 | 0.73 | 0.16 | Upgrade
|
| Other Intangible Assets | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | Upgrade
|
| Other Long-Term Assets | 0.05 | 0.08 | 0.13 | 0.1 | 0.1 | - | Upgrade
|
| Total Assets | 37.8 | 39.56 | 57 | 81.8 | 99.95 | 40.66 | Upgrade
|
| Accounts Payable | 7.2 | 6.54 | 7.9 | 5.21 | 3.8 | 1.52 | Upgrade
|
| Accrued Expenses | - | 0.03 | 0.04 | 0.01 | 0.01 | 0.03 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 9.92 | 5 | - | - | Upgrade
|
| Current Portion of Leases | 0.15 | 0.14 | 0.12 | 0.09 | 0.07 | 0.03 | Upgrade
|
| Other Current Liabilities | 0.58 | 0.52 | 0.49 | 0.62 | 0.47 | 0.19 | Upgrade
|
| Total Current Liabilities | 7.93 | 7.22 | 18.47 | 10.92 | 4.36 | 1.78 | Upgrade
|
| Long-Term Debt | - | - | - | 9.7 | 14.46 | - | Upgrade
|
| Long-Term Leases | 0.2 | 0.24 | 0.4 | 0.53 | 0.7 | 0.13 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0.55 | 0.2 | - | Upgrade
|
| Total Liabilities | 8.13 | 7.47 | 18.86 | 21.69 | 19.72 | 1.9 | Upgrade
|
| Common Stock | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 203.1 | 195.75 | 159.14 | 151.8 | 143.92 | 72.11 | Upgrade
|
| Retained Earnings | -172.84 | -163.1 | -121.02 | -91.01 | -63.72 | -33.38 | Upgrade
|
| Comprehensive Income & Other | -0.61 | -0.58 | -0.8 | -0.7 | 0 | 0.01 | Upgrade
|
| Total Common Equity | 29.67 | 32.1 | 37.34 | 60.1 | 80.23 | 38.75 | Upgrade
|
| Shareholders' Equity | 29.67 | 32.1 | 38.14 | 60.1 | 80.23 | 38.75 | Upgrade
|
| Total Liabilities & Equity | 37.8 | 39.56 | 57 | 81.8 | 99.95 | 40.66 | Upgrade
|
| Total Debt | 0.35 | 0.38 | 10.44 | 15.31 | 15.23 | 0.16 | Upgrade
|
| Net Cash (Debt) | 18.99 | 20.54 | 25.41 | 36.84 | 59.58 | 21.81 | Upgrade
|
| Net Cash Growth | 5.14% | -19.18% | -31.03% | -38.16% | 173.20% | 219.42% | Upgrade
|
| Net Cash Per Share | 0.90 | 1.03 | 1.41 | 2.06 | 3.69 | 1.82 | Upgrade
|
| Filing Date Shares Outstanding | 23.21 | 22.93 | 17.95 | 17.95 | 17.86 | 14.93 | Upgrade
|
| Total Common Shares Outstanding | 22.93 | 22.28 | 17.95 | 17.95 | 17.84 | 13.48 | Upgrade
|
| Working Capital | 13.03 | 15.44 | 21.48 | 53.76 | 78.25 | 22.21 | Upgrade
|
| Book Value Per Share | 1.29 | 1.44 | 2.08 | 3.35 | 4.50 | 2.87 | Upgrade
|
| Tangible Book Value | 13.16 | 15.58 | 20.83 | 43.59 | 63.71 | 22.24 | Upgrade
|
| Tangible Book Value Per Share | 0.57 | 0.70 | 1.16 | 2.43 | 3.57 | 1.65 | Upgrade
|
Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.